Literature DB >> 27566412

Pathophysiology of lymphedema-Is there a chance for medication treatment?

Geoffrey E Hespe1, Gabriela Garcia Nores1, Jung-Ju Huang1,2,3, Babak J Mehrara1.   

Abstract

Lymphedema is a common morbid after cancer treatment. The disease characterizes with progressive inflammatory process that result in irreversible fibrosis. Its chronology and progressive disease character often impacts the quality of life of cancer survivors. The pathophysiology of lymphedema remains unclear and the disease remains non-curable. In this article, we reviewed available studies of lymphedema and concluded possible treatment strategies for lymphedema. J. Surg. Oncol. 2017;115:96-98.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  T-cell; inflammation; lymphedema

Mesh：

Year:  2016        PMID： 27566412     DOI： 10.1002/jso.24414

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  8 in total

Review 1.  Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments.

Authors:  Tessa C Gillespie; Hoda E Sayegh; Cheryl L Brunelle; Kayla M Daniell; Alphonse G Taghian
Journal:  Gland Surg       Date:  2018-08

2.  Subclinical Lymphedema After Treatment for Breast Cancer: Risk of Progression and Considerations for Early Intervention.

Authors:  Loryn K Bucci; Cheryl L Brunelle; Madison C Bernstein; Amy M Shui; Tessa C Gillespie; Sacha A Roberts; George E Naoum; Alphonse G Taghian
Journal:  Ann Surg Oncol       Date:  2021-06-11       Impact factor: 5.344

3.  Obese patients have higher risk of breast cancer-related lymphedema than overweight patients after breast cancer: a meta-analysis.

Authors:  Ruxing Wu; Xiaoyuan Huang; Xiyuan Dong; Hanwang Zhang; Liang Zhuang
Journal:  Ann Transl Med       Date:  2019-04

4.  Photoacoustic lymphangiography before and after lymphaticovenular anastomosis.

Authors:  Anna Oh; Hiroki Kajita; Eri Matoba; Keisuke Okabe; Hisashi Sakuma; Nobuaki Imanishi; Yoshifumi Takatsume; Hikaru Kono; Yasufumi Asao; Takayuki Yagi; Sadakazu Aiso; Kazuo Kishi
Journal:  Arch Plast Surg       Date:  2021-05-15

5.  Selenium Deficiency in Lymphedema and Lipedema-A Retrospective Cross-Sectional Study from a Specialized Clinic.

Authors:  Christina Pfister; Horst Dawczynski; Franz-Josef Schingale
Journal:  Nutrients       Date:  2020-04-25       Impact factor: 5.717

6.  The effects of synbiotic supplementation on serum inflammatory markers and edema volume in breast cancer survivors with lymphedema.

Authors:  Saeideh Vafa; Shahpar Haghighat; Leila Janani; Ali Saneei Totmaj; Mehraban Navaei; Ali Amirinejad; Hadi Emamat; Zahra Salehi; Mitra Zarrati
Journal:  EXCLI J       Date:  2020-01-02       Impact factor: 4.068

Review 7.  Restorative oncodermatology: Diagnosis and management of dermatologic sequelae from cancer therapies.

Authors:  Anthony M Rossi; Brian P Hibler; Cristian Navarrete-Dechent; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2020-08-08       Impact factor: 15.487

8.  Single Center Retrospective Analysis of Cost and Payments for Lymphatic Surgery.

Authors:  Alan R Tom; Elizabeth Boudiab; Christopher Issa; Kristine Huynh; Stephen Lu; Jeremy M Powers; Kongkrit Chaiyasate
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-06-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.